| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |